{"0": {"lymphocytic leukemia": 0.6218310594558716, "leukemia": 0.5742871165275574, "leukemia hematology": 0.5705573558807373, "lymphocytic leukaemia": 0.5043347477912903, "follicular lymphoma": 0.49439042806625366, "leukaemia": 0.486515611410141, "lymphoma": 0.48650771379470825, "chronic lymphocytic": 0.486042857170105, "patients with chronic": 0.4652567505836487, "hematologist oncologist": 0.4363994598388672, "remission": 0.42531245946884155, "oncologist": 0.4041033983230591, "chronic": 0.39237189292907715, "chemo": 0.3729029595851898, "blood cancer": 0.36791375279426575, "refractory chronic": 0.36438503861427307, "chemotherapy": 0.3459430932998657, "cancer survivors": 0.33975300192832947, "chemotherapy free": 0.3247601389884949, "cancer therapy": 0.3073120713233948, "cancer center": 0.2905411720275879, "diagnosed": 0.2850819230079651, "lymphocyte": 0.2807728052139282, "hematologist": 0.27873319387435913, "tumor lysis": 0.27371305227279663, "my wbc": 0.2686479687690735, "hematology": 0.26849421858787537, "oncology": 0.2643420100212097, "combination therapies": 0.2624386250972748, "cancer": 0.2618538737297058, "immune response": 0.26119470596313477, "newly diagnosed": 0.254212349653244, "disease progression": 0.2534103989601135, "wbc": 0.25127893686294556, "blood work": 0.2509942948818207, "immunotherapy": 0.24930618703365326, "treatment options": 0.2492324858903885, "novartis": 0.24753545224666595, "bone marrow": 0.24746432900428772, "lymphocyte count": 0.246165931224823, "targeted therapies": 0.24503344297409058, "therapies": 0.24487203359603882, "enlarged lymph": 0.24092155694961548, "treatments": 0.2400393784046173, "blood cancers": 0.22518184781074524, "lymphocytes": 0.2197507917881012, "clinical trials": 0.21912281215190887, "was diagnosed": 0.21637248992919922, "cancer network": 0.21200627088546753, "clinical trial": 0.2117956578731537}, "1": {"dr wierda": 0.5661596059799194, "dr danilov": 0.5627828240394592, "dr barrientos": 0.553609311580658, "dr brander": 0.5380387902259827, "dr shadman": 0.5361422896385193, "dr woyach": 0.5251790285110474, "dr abedin": 0.4919695258140564, "dr": 0.4864780306816101, "dr mato": 0.4789440929889679, "dr ghia": 0.4208974838256836, "dr byrd": 0.41399767994880676, "dr davids": 0.4062156081199646, "novartis": 0.3263072669506073, "my doctor": 0.3145262897014618, "cll": 0.29948556423187256, "cll sll": 0.2993912696838379, "doctor": 0.2969210147857666, "patients with chronic": 0.286760538816452, "my doc": 0.2859323024749756, "md anderson": 0.2727620601654053, "targeted therapies": 0.25847458839416504, "hematologist oncologist": 0.2516111135482788, "doc": 0.2515679597854614, "oncologist": 0.24792537093162537, "clinical trial": 0.24207162857055664, "hematology advisor": 0.2406548261642456, "md": 0.2269684225320816, "doctors": 0.22642958164215088, "therapies": 0.21988698840141296, "treatment paradigm": 0.21762490272521973, "chronic lymphocytic": 0.21368074417114258, "follicular lymphoma": 0.21081578731536865, "clinical trials": 0.21066725254058838, "cancer therapy": 0.2081792950630188, "therapeutics announces": 0.20770901441574097, "immunotherapy": 0.2036662995815277, "tg therapeutics": 0.20092332363128662, "combination therapies": 0.19448858499526978, "tumor lysis": 0.19370712339878082, "oncology": 0.1906462460756302, "newly diagnosed": 0.1901826560497284, "fda grants": 0.18960919976234436, "diagnosed": 0.18916085362434387, "fda approves": 0.18798427283763885, "cancer center": 0.1815517693758011, "treatment options": 0.18013019859790802, "btk inhibitor": 0.17957136034965515, "was diagnosed": 0.17851987481117249, "tumor": 0.17664986848831177, "fda": 0.17632628977298737}, "2": {"treatment paradigm": 0.4936119019985199, "therapies": 0.4013335406780243, "treatment options": 0.4001285433769226, "combination therapies": 0.39489638805389404, "targeted therapies": 0.3926464319229126, "treatment": 0.3711510896682739, "combination therapy": 0.36571237444877625, "therapy": 0.35174912214279175, "targeted therapy": 0.3500150144100189, "cancer therapy": 0.3388884961605072, "treatment naive": 0.33508479595184326, "treatments": 0.33240294456481934, "treating": 0.30207324028015137, "treatment landscape": 0.3004654347896576, "treated": 0.2897610068321228, "newly diagnosed": 0.28296953439712524, "previously treated": 0.27661019563674927, "cell therapy": 0.27589261531829834, "therapeutic": 0.2728007435798645, "cll sll": 0.25995761156082153, "oncologist": 0.2573661208152771, "remission": 0.24510407447814941, "therapeutics announces": 0.24214820563793182, "cure": 0.24071016907691956, "rituximab combo": 0.2328154444694519, "chemo": 0.2323531210422516, "cll": 0.23015618324279785, "therapeutics": 0.22852972149848938, "chemotherapy": 0.2280825972557068, "novartis": 0.2253950536251068, "hematologist oncologist": 0.22070235013961792, "follicular lymphoma": 0.2187245488166809, "tg therapeutics": 0.21621468663215637, "hematology advisor": 0.2135678380727768, "diagnosed": 0.21148690581321716, "treat": 0.2064882218837738, "obinutuzumab combo": 0.20031499862670898, "oncology": 0.19929221272468567, "cancer center": 0.19888532161712646, "fda approves": 0.19518136978149414, "relapsed refractory": 0.19277188181877136, "disease progression": 0.18950659036636353, "fda approval": 0.1861395537853241, "lymphoma": 0.18488018214702606, "dr barrientos": 0.17850062251091003, "patients with chronic": 0.17706435918807983, "lymphocytic leukemia": 0.17554298043251038, "dr wierda": 0.17332038283348083, "lymphocytic leukaemia": 0.1682121455669403, "previously untreated": 0.1663169115781784}, "3": {"cancer therapy": 0.5571813583374023, "oncologist": 0.4790034890174866, "cancer center": 0.4429122805595398, "chemo": 0.4346587061882019, "hematologist oncologist": 0.4156884551048279, "chemotherapy": 0.4087914824485779, "cancer": 0.39549875259399414, "cancer survivors": 0.3897244334220886, "follicular lymphoma": 0.38837724924087524, "therapy": 0.3706893026828766, "chemotherapy free": 0.3700809180736542, "lymphoma": 0.36375606060028076, "cancers": 0.35950908064842224, "therapies": 0.3528776168823242, "oncology": 0.3521406054496765, "cancer network": 0.348611980676651, "blood cancer": 0.34743186831474304, "lymphocytic leukemia": 0.3305244445800781, "remission": 0.31890588998794556, "combination therapies": 0.3174780309200287, "treatment options": 0.3145749568939209, "treatment paradigm": 0.31389719247817993, "leukemia": 0.3084278404712677, "cell therapy": 0.3067529797554016, "combination therapy": 0.3034784495830536, "targeted therapy": 0.2996573746204376, "treatments": 0.2975451946258545, "treatment": 0.2968655228614807, "targeted therapies": 0.29609331488609314, "hematology advisor": 0.2956015467643738, "leukemia hematology": 0.2910161018371582, "treatment naive": 0.28734439611434937, "lymphocytic leukaemia": 0.2824917733669281, "therapeutic": 0.27753913402557373, "leukaemia": 0.270199179649353, "blood cancers": 0.26548948884010315, "newly diagnosed": 0.26456180214881897, "therapeutics": 0.26249948143959045, "treated": 0.2327088713645935, "support group": 0.2314731478691101, "treating": 0.23134812712669373, "tumor lysis": 0.2302732914686203, "patients with chronic": 0.22959885001182556, "advisor": 0.22853843867778778, "previously treated": 0.22730876505374908, "fda approval": 0.22298939526081085, "novartis": 0.22231948375701904, "immunotherapy": 0.22155264019966125, "cll": 0.2213219702243805, "cure": 0.2139180302619934}, "4": {"patients with chronic": 0.48210573196411133, "patients": 0.4665701985359192, "elderly patients": 0.4392241835594177, "older patients": 0.43753448128700256, "younger patients": 0.4184117317199707, "patient": 0.3793497383594513, "hematologist oncologist": 0.29956746101379395, "targeted therapies": 0.28728359937667847, "oncologist": 0.28606101870536804, "follicular lymphoma": 0.2690255641937256, "lymphocytic leukemia": 0.2387627363204956, "lymphocytic leukaemia": 0.2355412244796753, "dr wierda": 0.23385179042816162, "elderly": 0.2272689938545227, "therapies": 0.22561383247375488, "novartis": 0.22122952342033386, "remission": 0.21787557005882263, "leukemia hematology": 0.21206918358802795, "dr danilov": 0.20930811762809753, "cll": 0.2092273235321045, "previously untreated": 0.2085457593202591, "targeted therapy": 0.2025759220123291, "lymphoma": 0.201666921377182, "leukaemia": 0.19640043377876282, "dr barrientos": 0.19608178734779358, "dr abedin": 0.19411228597164154, "previously treated": 0.19356876611709595, "leukemia": 0.19101472198963165, "combination therapies": 0.18897831439971924, "hematologist": 0.18655775487422943, "chemotherapy": 0.18580038845539093, "cll sll": 0.18567824363708496, "high risk": 0.18530860543251038, "chemo": 0.18508319556713104, "dr": 0.18088436126708984, "refractory cll": 0.1766357570886612, "treatment naive": 0.17641612887382507, "treatment paradigm": 0.17598408460617065, "chemotherapy free": 0.17358960211277008, "newly diagnosed": 0.1715877205133438, "standard of care": 0.1710108369588852, "cancer therapy": 0.17082667350769043, "diagnosed": 0.1682363897562027, "doctors": 0.16692017018795013, "disease progression": 0.16672389209270477, "dr woyach": 0.16386759281158447, "cell transplant": 0.1634415090084076, "lymphocyte": 0.16317863762378693, "treatment options": 0.16303518414497375, "immune response": 0.16283561289310455}, "5": {"improves pfs": 0.3029516041278839, "prolongs pfs": 0.2545776069164276, "previously untreated": 0.23509618639945984, "cll sll": 0.2319706678390503, "pfs": 0.23059289157390594, "follicular lymphoma": 0.22371135652065277, "refractory cll": 0.21441471576690674, "immune response": 0.21323208510875702, "cll": 0.20862624049186707, "refractory chronic": 0.2046414017677307, "response rates": 0.20281314849853516, "response rate": 0.18655052781105042, "ibrutinib plus": 0.1841198354959488, "hematology advisor": 0.18332377076148987, "novartis": 0.18193107843399048, "chronic lymphocytic": 0.1804623007774353, "lymphocytic leukemia": 0.17969173192977905, "elevate tn": 0.17858274281024933, "high risk": 0.17685911059379578, "fda approval": 0.1706322431564331, "rituximab combo": 0.16564685106277466, "hematologist oncologist": 0.16505546867847443, "previously treated": 0.16502068936824799, "lymphocytic leukaemia": 0.16299346089363098, "fda approves": 0.16210207343101501, "leukemia hematology": 0.15860293805599213, "lymphoma": 0.1552574336528778, "undetectable mrd": 0.1548863649368286, "targeted therapies": 0.15483275055885315, "untreated": 0.15334534645080566, "newly diagnosed": 0.15324647724628448, "plus rituximab": 0.15274812281131744, "btk inhibitor": 0.15226462483406067, "relapsed refractory": 0.15044941008090973, "disease progression": 0.149766206741333, "lymphocyte": 0.14908644556999207, "patients with chronic": 0.14675825834274292, "oncologist": 0.14615701138973236, "combos": 0.13926585018634796, "treatment naive": 0.13726365566253662, "remission": 0.1353926658630371, "mcl": 0.13485296070575714, "response": 0.13468438386917114, "combination therapies": 0.13416051864624023, "obinutuzumab combo": 0.13331450521945953, "reply": 0.13284221291542053, "second opinion": 0.1326070874929428, "advances": 0.12901003658771515, "my wbc": 0.124662384390831, "therapeutics announces": 0.12448238581418991}, "6": {"cell therapy": 0.5633869171142578, "cell transplant": 0.4279320538043976, "cell malignancies": 0.39178767800331116, "car cells": 0.38642507791519165, "cancer therapy": 0.38084232807159424, "car cell": 0.3757532835006714, "therapy": 0.353603333234787, "lymphocytic leukaemia": 0.33613014221191406, "lymphocytic leukemia": 0.326123982667923, "targeted therapy": 0.3173066973686218, "leukemia hematology": 0.3166906237602234, "follicular lymphoma": 0.30202460289001465, "cell": 0.2869935631752014, "hematologist oncologist": 0.27828162908554077, "cells": 0.27721795439720154, "leukaemia": 0.27207839488983154, "oncologist": 0.27122554183006287, "chemotherapy": 0.26907455921173096, "chemo": 0.2671377658843994, "leukemia": 0.2664562463760376, "chemotherapy free": 0.2645235061645508, "therapies": 0.2637254297733307, "lymphoma": 0.258270800113678, "cancer center": 0.2515842914581299, "tumor lysis": 0.2501983642578125, "lymphocyte": 0.2487480491399765, "hematology": 0.24821648001670837, "targeted therapies": 0.24784737825393677, "cancer survivors": 0.24542850255966187, "relapsed refractory": 0.24415786564350128, "lymphocytes": 0.2400343418121338, "treatment paradigm": 0.23176240921020508, "remission": 0.22984495759010315, "combination therapy": 0.22375726699829102, "novartis": 0.22062623500823975, "treatments": 0.21999743580818176, "therapeutic": 0.2175988256931305, "treatment options": 0.21718260645866394, "immune response": 0.2171517163515091, "cancer": 0.2146996557712555, "inhibitor": 0.2143745720386505, "blood cancer": 0.21367621421813965, "btk inhibitor": 0.2129363715648651, "oncology": 0.21269118785858154, "btk inhibitors": 0.21260543167591095, "treatment": 0.2117696851491928, "liso cel": 0.20153658092021942, "patients with chronic": 0.19862166047096252, "combination therapies": 0.1977621614933014, "immunotherapy": 0.18894442915916443}, "7": {"relapsed refractory": 0.6924294233322144, "relapsed": 0.5357074737548828, "refractory cll": 0.4801924228668213, "refractory chronic": 0.4358617961406708, "refractory": 0.39028871059417725, "follicular lymphoma": 0.24384728074073792, "remission": 0.23094789683818817, "cll sll": 0.21055379509925842, "cell therapy": 0.20914050936698914, "cure": 0.2017061710357666, "btk inhibition": 0.19127580523490906, "lymphoma": 0.18352638185024261, "richter transformation": 0.18077781796455383, "lymphocytic leukemia": 0.17986010015010834, "therapy": 0.17976310849189758, "cll": 0.17740197479724884, "immune response": 0.17035183310508728, "oncologist": 0.16872785985469818, "cancer therapy": 0.16850900650024414, "therapies": 0.1662234216928482, "lymphocytic leukaemia": 0.16519872844219208, "targeted therapy": 0.16402052342891693, "patients with chronic": 0.16283486783504486, "hematology advisor": 0.16232720017433167, "chronic lymphocytic": 0.16188564896583557, "treatment options": 0.16129626333713531, "inhibition": 0.15881669521331787, "hematologist oncologist": 0.15487653017044067, "treatment": 0.14855632185935974, "btk inhibitor": 0.1473478376865387, "leukemia hematology": 0.1447615623474121, "mcl": 0.14200198650360107, "inhibitor": 0.1409609019756317, "treatment paradigm": 0.1402185708284378, "hematologic malignancies": 0.1398656666278839, "treatment naive": 0.13916006684303284, "lymphocyte": 0.1366155445575714, "chemotherapy free": 0.13616380095481873, "targeted therapies": 0.13614104688167572, "chemotherapy": 0.13571877777576447, "wish you": 0.1355782002210617, "previously treated": 0.13459409773349762, "chronic": 0.13312190771102905, "previously untreated": 0.13294094800949097, "leukaemia": 0.1296246498823166, "disease progression": 0.12845896184444427, "md anderson": 0.12835019826889038, "immune": 0.12803547084331512, "chemo": 0.12783949077129364, "untreated": 0.12731745839118958}, "8": {"hematologist oncologist": 0.42684727907180786, "follicular lymphoma": 0.42615288496017456, "lymphoma": 0.39749854803085327, "oncologist": 0.3864540457725525, "lymphocytic leukemia": 0.38582271337509155, "leukaemia": 0.3782764971256256, "leukemia hematology": 0.3707071542739868, "lymphocytic leukaemia": 0.36980873346328735, "chemo": 0.3648514747619629, "remission": 0.35865795612335205, "chemotherapy": 0.3409020006656647, "chemotherapy free": 0.3402259051799774, "leukemia": 0.3365485370159149, "cancer therapy": 0.32505670189857483, "newly diagnosed": 0.32344311475753784, "lymphocyte": 0.3223201632499695, "blood cancer": 0.3206069767475128, "immunotherapy": 0.31771284341812134, "diagnosed": 0.31666213274002075, "therapies": 0.3071317672729492, "lymph nodes": 0.30690306425094604, "swollen lymph": 0.30089980363845825, "hematology": 0.2975395917892456, "patients": 0.29546451568603516, "hematologist": 0.2932402491569519, "targeted therapies": 0.2931438088417053, "treatments": 0.29157447814941406, "lymphocytes": 0.29084423184394836, "was diagnosed": 0.2875502109527588, "antibody": 0.2851743698120117, "treatment paradigm": 0.2829989790916443, "antibodies": 0.2825542390346527, "blood work": 0.2811673879623413, "cancer survivors": 0.2808203101158142, "lymphocyte count": 0.2803608775138855, "immune response": 0.27957677841186523, "lymph": 0.2739170789718628, "cell therapy": 0.2732996940612793, "oncology": 0.2728983163833618, "patients with chronic": 0.2728966474533081, "cancer network": 0.2725614011287689, "treatment": 0.2713415026664734, "tumor lysis": 0.27127134799957275, "enlarged lymph": 0.26891472935676575, "novartis": 0.26861506700515747, "treated": 0.268338680267334, "untreated": 0.2665465474128723, "my wbc": 0.26566123962402344, "covid vaccine": 0.2644839882850647, "vaccine": 0.2626289129257202}, "9": {"frontline": 0.6077117323875427, "front line": 0.4295288920402527, "targeted therapies": 0.2648279666900635, "previously treated": 0.254697322845459, "treatment paradigm": 0.23272937536239624, "novartis": 0.22598841786384583, "treatment options": 0.22085264325141907, "follicular lymphoma": 0.21677905321121216, "targeted therapy": 0.21474188566207886, "treatment naive": 0.21384331583976746, "cancer therapy": 0.2119964212179184, "dr barrientos": 0.2012413740158081, "cancer center": 0.19735562801361084, "treatment": 0.19189634919166565, "dr wierda": 0.1892852485179901, "vaccine": 0.18821518123149872, "treated": 0.18486224114894867, "clinical trial": 0.18412363529205322, "previously untreated": 0.18400296568870544, "combination therapies": 0.18278375267982483, "chemotherapy": 0.17825928330421448, "chemo": 0.17809203267097473, "covid vaccine": 0.17521154880523682, "therapies": 0.17378786206245422, "treatments": 0.1724039912223816, "clinical trials": 0.1717052459716797, "immunotherapy": 0.1698388159275055, "rituximab combo": 0.168197363615036, "chemotherapy free": 0.16678960621356964, "obinutuzumab combo": 0.16644176840782166, "patients with chronic": 0.16604751348495483, "disease progression": 0.1653861105442047, "dr danilov": 0.16011583805084229, "regimen": 0.15995752811431885, "vaccinated": 0.1595836579799652, "hematology advisor": 0.15892840921878815, "cancer survivors": 0.1554524153470993, "treatment landscape": 0.1546720266342163, "treating": 0.1531771421432495, "my doc": 0.15282166004180908, "combination therapy": 0.15160132944583893, "dr brander": 0.15145538747310638, "high risk": 0.14947350323200226, "newly diagnosed": 0.14781686663627625, "fda approves": 0.14646220207214355, "cll": 0.1461849957704544, "vaccination": 0.1458459198474884, "remission": 0.14532217383384705, "toxicity": 0.1449320912361145, "btk inhibitor": 0.1435803472995758}, "10": {"fda approval": 0.6691926717758179, "fda approves": 0.6645646095275879, "fda": 0.5842170715332031, "fda grants": 0.5507500171661377, "novartis": 0.42177510261535645, "therapeutics announces": 0.3472999930381775, "cll sll": 0.3286825716495514, "follicular lymphoma": 0.30545905232429504, "chemo": 0.2994445562362671, "oncologist": 0.29057323932647705, "hematologist oncologist": 0.2852311134338379, "approved": 0.27389317750930786, "chemotherapy": 0.27328383922576904, "cancer therapy": 0.2689228057861328, "cll": 0.26806703209877014, "lymphoma": 0.2656407654285431, "chemotherapy free": 0.25575992465019226, "oncology": 0.2548450529575348, "approves": 0.23925527930259705, "immunotherapy": 0.233921617269516, "approval": 0.23072372376918793, "targeted therapies": 0.22361980378627777, "previously treated": 0.2219099998474121, "lymphocytic leukemia": 0.22007113695144653, "lymphocytic leukaemia": 0.21680870652198792, "therapeutics": 0.21404483914375305, "treatment naive": 0.21328726410865784, "cancer": 0.21325331926345825, "remission": 0.21149380505084991, "cancer center": 0.20508497953414917, "leukaemia": 0.2049015909433365, "leukemia hematology": 0.20388348400592804, "combination therapies": 0.2037249058485031, "blood cancer": 0.20220112800598145, "therapies": 0.19801932573318481, "treating": 0.19351699948310852, "dr brander": 0.18781015276908875, "leukemia": 0.18769872188568115, "newly diagnosed": 0.18662193417549133, "hematology advisor": 0.18620529770851135, "dr barrientos": 0.1856604814529419, "medicare": 0.1801270842552185, "treatments": 0.17935490608215332, "vaccines": 0.1787206083536148, "cancer survivors": 0.17661428451538086, "treatment paradigm": 0.1755010187625885, "dr wierda": 0.17131902277469635, "treated": 0.17076079547405243, "covid vaccine": 0.17072702944278717, "refractory cll": 0.16524653136730194}, "11": {"lymphocytic leukemia": 0.41016680002212524, "patients with chronic": 0.3953876197338104, "chronic lymphocytic": 0.38738155364990234, "follicular lymphoma": 0.37949424982070923, "leukemia hematology": 0.37360456585884094, "remission": 0.37174540758132935, "refractory chronic": 0.37151676416397095, "leukemia": 0.36318081617355347, "lymphoma": 0.36284106969833374, "leukaemia": 0.34954744577407837, "relapsed refractory": 0.3444080948829651, "lymphocytic leukaemia": 0.34227487444877625, "chronic": 0.34030842781066895, "hematologist oncologist": 0.32098281383514404, "relapsed": 0.30732977390289307, "oncologist": 0.30638477206230164, "chemotherapy": 0.29182255268096924, "chemo": 0.2888646721839905, "chemotherapy free": 0.2788720428943634, "blood cancer": 0.2417251169681549, "lymphocyte": 0.24057306349277496, "cancer therapy": 0.23813611268997192, "treatment options": 0.22482377290725708, "newly diagnosed": 0.2208711951971054, "treatment": 0.22056585550308228, "hematologist": 0.21952852606773376, "therapies": 0.21804681420326233, "diagnosed": 0.21785464882850647, "treatments": 0.21669186651706696, "novartis": 0.2162507176399231, "patients": 0.21401658654212952, "immunotherapy": 0.21342253684997559, "lymphocyte count": 0.21069379150867462, "treatment paradigm": 0.21029901504516602, "clinical trial": 0.20801304280757904, "cell therapy": 0.2074320763349533, "treatment naive": 0.20699429512023926, "immune response": 0.20681189000606537, "oncology": 0.20605504512786865, "cure": 0.20486077666282654, "clinical trials": 0.20480233430862427, "targeted therapies": 0.20218470692634583, "targeted therapy": 0.20092420279979706, "support group": 0.2002309113740921, "was diagnosed": 0.20015859603881836, "cancer survivors": 0.19885453581809998, "hematology": 0.198411762714386, "refractory cll": 0.19610048830509186, "tumor lysis": 0.1950746774673462, "bone marrow": 0.19310925900936127}, "12": {"efficacy": 0.4745045602321625, "efficacy and safety": 0.4174579381942749, "safety and efficacy": 0.40465444326400757, "effective": 0.29803162813186646, "more effective": 0.256186306476593, "safe effective": 0.22247399389743805, "acalabrutinib demonstrates": 0.18944105505943298, "fixed duration": 0.17223963141441345, "positive results": 0.17099809646606445, "refractory chronic": 0.16542866826057434, "benefit": 0.15880635380744934, "novartis": 0.14551910758018494, "btk inhibitor": 0.143778994679451, "duration": 0.13835053145885468, "ibrutinib plus": 0.13518957793712616, "chronic lymphocytic": 0.13147617876529694, "therapeutics announces": 0.13136617839336395, "follicular lymphoma": 0.1268535703420639, "long term": 0.1257651299238205, "benefits": 0.12472869455814362, "outcomes": 0.12312794476747513, "undetectable mrd": 0.12292687594890594, "patients with chronic": 0.11987243592739105, "remission": 0.1168171837925911, "lymphocytic leukaemia": 0.11595623195171356, "combination therapy": 0.11573184281587601, "results": 0.11536362767219543, "targeted therapies": 0.1152748316526413, "best": 0.11417018622159958, "durable responses": 0.11369351297616959, "demonstrates": 0.1121426448225975, "immune response": 0.11153436452150345, "effect": 0.1105712503194809, "improved": 0.10886408388614655, "targeted therapy": 0.10713796317577362, "combination therapies": 0.10618246346712112, "dr shadman": 0.10494771599769592, "clinical trial": 0.10481119900941849, "side effects": 0.10401838272809982, "improves": 0.10367828607559204, "cll": 0.10199615359306335, "lymphocyte count": 0.10152940452098846, "promising": 0.1014612466096878, "chemotherapy": 0.10119650512933731, "treatment paradigm": 0.10047741234302521, "response rate": 0.09901605546474457, "lymphocytic": 0.09872568398714066, "inhibitor": 0.09811625629663467, "refractory cll": 0.09766087681055069, "cll sll": 0.0973072350025177}, "13": {"btk inhibitors": 0.6055686473846436, "btk inhibitor": 0.5839889049530029, "inhibitors": 0.5263493061065674, "inhibitor": 0.5017794370651245, "pi inhibitors": 0.42203184962272644, "btk inhibition": 0.3827891945838928, "hematology advisor": 0.30773505568504333, "dr danilov": 0.3001830279827118, "tumor lysis": 0.29383134841918945, "dr wierda": 0.2906767427921295, "dr barrientos": 0.27494049072265625, "dr shadman": 0.27329984307289124, "novartis": 0.2681039571762085, "oncology": 0.26378053426742554, "dr ghia": 0.2632957696914673, "hematology": 0.2632879912853241, "tg therapeutics": 0.26122409105300903, "hematologist oncologist": 0.25848862528800964, "inhibition": 0.2557465434074402, "targeted therapies": 0.25139516592025757, "follicular lymphoma": 0.24642065167427063, "oncologist": 0.2436653971672058, "dr abedin": 0.23709449172019958, "dr woyach": 0.23356488347053528, "undetectable mrd": 0.22977957129478455, "dr brander": 0.22879758477210999, "dr mato": 0.22694353759288788, "patients with chronic": 0.22570785880088806, "combination therapies": 0.22416304051876068, "cancer therapy": 0.21946482360363007, "immunotherapy": 0.2162589728832245, "lymphocyte": 0.21570155024528503, "therapeutics": 0.21548371016979218, "cell transplant": 0.20957712829113007, "therapeutics announces": 0.2067728042602539, "refractory chronic": 0.20495229959487915, "therapies": 0.20353005826473236, "refractory cll": 0.202467143535614, "md anderson": 0.20241938531398773, "combination therapy": 0.20194187760353088, "lymphocytic leukaemia": 0.20079313218593597, "dr": 0.20004896819591522, "cell therapy": 0.19645851850509644, "leukemia hematology": 0.19498661160469055, "my doctor": 0.1922447681427002, "cll sll": 0.19199250638484955, "btk": 0.19082312285900116, "diagnosed": 0.18951177597045898, "tumor": 0.18860730528831482, "mcl": 0.18751630187034607}, "14": {"patients with chronic": 0.4679226279258728, "patients": 0.433768093585968, "elderly patients": 0.4326898455619812, "targeted therapies": 0.42209288477897644, "older patients": 0.39055705070495605, "treatment options": 0.379717081785202, "treatment paradigm": 0.3768666982650757, "younger patients": 0.37166374921798706, "therapies": 0.3457539677619934, "patient": 0.3422517478466034, "targeted therapy": 0.3289455771446228, "hematologist oncologist": 0.3029118776321411, "treatment": 0.3024284243583679, "treatment naive": 0.2983863949775696, "oncologist": 0.29297876358032227, "treatment landscape": 0.28211110830307007, "dr wierda": 0.2776404023170471, "treatments": 0.2772630453109741, "combination therapies": 0.26638880372047424, "cancer therapy": 0.25978219509124756, "dr barrientos": 0.24877747893333435, "remission": 0.24676641821861267, "follicular lymphoma": 0.24558444321155548, "dr danilov": 0.24261422455310822, "chemo": 0.2396114319562912, "elderly": 0.23157909512519836, "therapy": 0.21158212423324585, "dr abedin": 0.21032869815826416, "novartis": 0.2098504900932312, "combination therapy": 0.2060490846633911, "treated": 0.20526692271232605, "diagnosed": 0.20408369600772858, "chemotherapy": 0.20161214470863342, "cure": 0.20145341753959656, "cell therapy": 0.20057012140750885, "lymphocytic leukaemia": 0.19602012634277344, "leukemia hematology": 0.19567321240901947, "dr woyach": 0.19566503167152405, "therapeutic": 0.1955825686454773, "previously treated": 0.19535377621650696, "newly diagnosed": 0.19399532675743103, "dr davids": 0.1936432123184204, "treating": 0.18869392573833466, "cll": 0.18658626079559326, "tg therapeutics": 0.18441948294639587, "dr brander": 0.18362930417060852, "lymphocytic leukemia": 0.18327777087688446, "dr shadman": 0.18266087770462036, "dr": 0.17869067192077637, "cell transplant": 0.17831330001354218}, "15": {"vaccinated": 0.52379310131073, "covid vaccine": 0.5177735686302185, "antibodies": 0.4974846839904785, "vaccines": 0.49328866600990295, "vaccine": 0.4766666293144226, "antibody": 0.47144943475723267, "leukemia hematology": 0.4627993106842041, "vaccination": 0.46220335364341736, "fully vaccinated": 0.45332735776901245, "lymphocytic leukemia": 0.43659359216690063, "lymphocytic leukaemia": 0.4300684928894043, "hematologist oncologist": 0.41483938694000244, "leukaemia": 0.41187775135040283, "leukemia": 0.40354976058006287, "immune response": 0.39840614795684814, "follicular lymphoma": 0.39506036043167114, "blood cancer": 0.3916897773742676, "chemotherapy free": 0.35248488187789917, "oncologist": 0.3475901186466217, "blood cancers": 0.34729933738708496, "immune": 0.34294044971466064, "cancer survivors": 0.3370538353919983, "lymphoma": 0.33097827434539795, "lymphocyte": 0.3245980739593506, "chemotherapy": 0.31809648871421814, "chemo": 0.306102454662323, "cancer network": 0.303358793258667, "lymphocytes": 0.2998831272125244, "cancer center": 0.29901039600372314, "immune system": 0.2926827073097229, "hematology": 0.28694161772727966, "hematologist": 0.2851506173610687, "patients with chronic": 0.2842848598957062, "immunotherapy": 0.28396087884902954, "remission": 0.28257742524147034, "lymphocyte count": 0.2775968313217163, "cancers": 0.274383008480072, "bone marrow": 0.2740687429904938, "white blood": 0.2625933587551117, "patients": 0.26139700412750244, "novartis": 0.26091405749320984, "cancer": 0.25806671380996704, "cancer therapy": 0.25798481702804565, "lymph nodes": 0.2508074641227722, "younger patients": 0.24226953089237213, "fda grants": 0.23916278779506683, "targeted therapies": 0.23127320408821106, "cell transplant": 0.22422240674495697, "anti": 0.2232082188129425, "fda approval": 0.22303393483161926}, "16": {"phase trial": 0.5494276285171509, "phase study": 0.4478803873062134, "phase iii": 0.41788971424102783, "phase ii": 0.3983403444290161, "clinical trial": 0.3717251420021057, "phase": 0.3567347824573517, "clinical trials": 0.32235798239707947, "captivate trial": 0.2925064265727997, "trial": 0.2532738745212555, "stage": 0.23461589217185974, "trials": 0.2103709578514099, "early stage": 0.20827344059944153, "treatment paradigm": 0.19637301564216614, "newly diagnosed": 0.18408551812171936, "captivate study": 0.18312761187553406, "obinutuzumab combo": 0.17668616771697998, "rituximab combo": 0.17031031847000122, "combo": 0.15559767186641693, "combos": 0.15460336208343506, "clinical": 0.13722658157348633, "iii": 0.13451185822486877, "previously untreated": 0.1334119290113449, "diagnosed": 0.12970930337905884, "relapsed refractory": 0.12462005764245987, "cll": 0.1225225105881691, "discusses": 0.12063710391521454, "treatment naive": 0.12034445255994797, "tg therapeutics": 0.11952437460422516, "follicular lymphoma": 0.11933136731386185, "six months": 0.11805251240730286, "triplet": 0.11797822266817093, "remission": 0.11446842551231384, "paradigm": 0.11314217746257782, "blood work": 0.11003901064395905, "ii": 0.10971198976039886, "trying": 0.108936607837677, "untreated": 0.10823625326156616, "am trying": 0.10788676142692566, "targeted therapies": 0.10642729699611664, "progression": 0.10612025111913681, "combination therapies": 0.10518208146095276, "me": 0.10448505729436874, "testing": 0.1034744530916214, "patient": 0.10148796439170837, "second opinion": 0.10132598131895065, "richter transformation": 0.10121974349021912, "support group": 0.09977713227272034, "hematologist oncologist": 0.09893112629652023, "btk inhibition": 0.09792277216911316, "refractory chronic": 0.0973561704158783}, "17": {"mutation": 0.5205065608024597, "mutations": 0.5095617175102234, "gene": 0.36589285731315613, "lymphocytic leukaemia": 0.3175322711467743, "tumor lysis": 0.31344833970069885, "genetic": 0.2981380224227905, "leukemia hematology": 0.29178211092948914, "cell transplant": 0.2874166667461395, "lymphocytic leukemia": 0.26424694061279297, "follicular lymphoma": 0.2553217113018036, "leukaemia": 0.2513389587402344, "hematologist oncologist": 0.2435705065727234, "hematology": 0.235275998711586, "hematologist": 0.2331210970878601, "disease progression": 0.22590743005275726, "transplant": 0.21726739406585693, "remission": 0.21645782887935638, "richter transformation": 0.20951369404792786, "immunotherapy": 0.20935451984405518, "lymphocyte": 0.2069188952445984, "oncologist": 0.20649203658103943, "tumor": 0.20009469985961914, "prognostic": 0.19692784547805786, "leukemia": 0.19619885087013245, "cll": 0.19040662050247192, "immune system": 0.18801268935203552, "lymphoma": 0.1858954131603241, "immune response": 0.17790740728378296, "prognostic factors": 0.17628511786460876, "immune": 0.1754317283630371, "newly diagnosed": 0.1746559590101242, "blood cancer": 0.16802498698234558, "cell malignancies": 0.16644443571567535, "chemotherapy": 0.165897935628891, "diagnosed": 0.1610105186700821, "antibodies": 0.15602008998394012, "my wbc": 0.1537761241197586, "chemotherapy free": 0.14961910247802734, "oncology": 0.14661571383476257, "fully vaccinated": 0.1461479812860489, "marrow": 0.14248642325401306, "undetectable mrd": 0.14178483188152313, "patients with chronic": 0.1395586133003235, "resistance": 0.13930565118789673, "vaccinated": 0.13520361483097076, "cell therapy": 0.1346331089735031, "chemo": 0.1345425844192505, "disease": 0.13357456028461456, "wbc": 0.13354550302028656, "bone marrow": 0.1333601027727127}, "18": {"survival benefit": 0.5603828430175781, "survival": 0.4613438844680786, "cancer survivors": 0.3392461836338043, "follicular lymphoma": 0.2842600345611572, "lymphoma": 0.2448648363351822, "lymphocytic leukemia": 0.24391791224479675, "lymphocytic leukaemia": 0.23814460635185242, "remission": 0.23363539576530457, "chemo": 0.2329137623310089, "cll sll": 0.22135350108146667, "chemotherapy free": 0.21106664836406708, "leukemia hematology": 0.210843026638031, "leukemia": 0.20798444747924805, "disease progression": 0.2022247314453125, "oncologist": 0.20166254043579102, "cell transplant": 0.19264595210552216, "leukaemia": 0.19190222024917603, "relapsed refractory": 0.1914738565683365, "cll": 0.19143864512443542, "cancer therapy": 0.19099554419517517, "chemotherapy": 0.18934407830238342, "newly diagnosed": 0.1771477460861206, "immune response": 0.17428335547447205, "cancer": 0.17301976680755615, "hematologist oncologist": 0.1694442480802536, "cancer network": 0.16935892403125763, "benefits": 0.16814708709716797, "cancer center": 0.16654425859451294, "relapsed": 0.1607687771320343, "blood cancer": 0.1595718264579773, "immune": 0.15775734186172485, "lymphocyte": 0.15536938607692719, "previously untreated": 0.15306344628334045, "tumor lysis": 0.1526980847120285, "tg therapeutics": 0.1434462070465088, "progression": 0.1430216133594513, "combination therapies": 0.1407833695411682, "bone marrow": 0.13980603218078613, "immune system": 0.13973936438560486, "chronic lymphocytic": 0.13893702626228333, "improves pfs": 0.13746696710586548, "cell therapy": 0.13689976930618286, "therapeutics announces": 0.13536621630191803, "obinutuzumab combo": 0.13495764136314392, "antibodies": 0.13454127311706543, "previously treated": 0.13300412893295288, "transplant": 0.13187509775161743, "combination therapy": 0.13110025227069855, "oncology": 0.13087619841098785, "cancers": 0.1294272392988205}}